2024 ESC Guidelines for the management of chronic coronary syndromes

ESC Clinical Practice Guidelines

30 Aug 2024

The current guidelines for managing chronic coronary syndromes (CCS) are intended to assist in diagnosing and initiating treatment for individuals with suspected CCS, as well as in the longterm management of patients with confirmed CCS. These guidelines recommend using a risk factor-weighted clinical likelihood model to estimate the most up-to-date clinical likelihood of obstructive coronary artery disease (CAD). Compared to the basic 2019 ESC pre-test probability model, incorporating risk factors into the pre-test likelihood model (which considers age, sex, and symptoms) enhances the prediction of obstructive CAD. This approach reclassifies more individuals into the very low and low likelihood categories, where further testing may be unnecessary. An updated diagnostic algorithm is provided for patients with moderate or high pre-test likelihood. The Guidelines also include an expanded section on diagnosing and treating patients with angina and no or nonobstructive coronary artery disease, now termed ANOCA-INOCA. The treatment section offers guidance on anti-anginal/anti-ischaemic medications and various event-preventing therapies. It also covers strategies to improve adherence to medical treatment and prescribed lifestyle changes. Additionally, the guidelines review indications for and selection of the optimal revascularisation modality based on findings from large RCTs and IPDAs. Lastly, options for managing recurrent or refractory angina/ischaemia are discussed.

Guidelines and related materials are for use by individuals for personal or educational purposes. No commercial use is allowed. Re-use permission must be correctly obtained from the publisher.

ESC Guidelines are protected by copyright. As per opt out option under Article 4 §3 of EU Directive 2019/790, the ESC reserves all rights to license uses of ESC Guidelines to train or develop generative artificial intelligence (AI) models, large language models or other deep learning or machine learning models. Any use of ESC Guidelines in software tools, generative AI models, computational models, or algorithms in which ESC Guideline content is included, cited, or transformed in any way requires a formal license agreement.

Topic(s):

Coronary Artery Disease (Chronic)

Endorsed by cardiac societies

Armenian Cardiologists Association , Azerbaijan Society of Cardiology , Belgian Society of Cardiology , Croatian Cardiac Society , Czech Society of Cardiology , Danish Society of Cardiology , Egyptian Society of Cardiology , Estonian Society of Cardiology , Finnish Cardiac Society , French Society of Cardiology , German Cardiac Society , Hellenic Society of Cardiology , Hungarian Society of Cardiology , Irish Cardiac Society , Israel Heart Society , Italian Federation of Cardiology , Kyrgyz Society of Cardiology , Latvian Society of Cardiology , Libyan Cardiac Society , Luxembourg Society of Cardiology , Maltese Cardiac Society , National Society of Cardiology of North Macedonia , Polish Cardiac Society , Austrian Society of Cardiology , Portuguese Society of Cardiology , San Marino Society of Cardiology , Cardiology Society of Serbia , Slovak Society of Cardiology , Slovenian Society of Cardiology , Spanish Society of Cardiology , Swiss Society of Cardiology , Turkish Society of Cardiology , Ukrainian Association of Cardiology

Main resources

: Full text and related materials

Full text

https://doi.org/10.1093/eurheartj/ehae177

Declarations of interest

Read the full text

: Scientific Presentation at ESC Congress 2024

Watch the video or consult the slides

Don't miss

More resources

: Slide set

Educational material.

Download

: ESC TV Interview

The essentials of the Guidelines in less than four minutes.

Watch

: Congress News Article

Insights from the Chairs of the Guidelines Task Force.

Read

: ESC Pocket Guidelines App

Have the ESC Pocket Guidelines with you all the time.

Download for free

Back to ESC Guidelines list